More articles from MTA II: Endocrine/Neuroendocrine Posters

You have access
Suspected hyperplastic parathyroid glands: Are they visualized on FDG-PET/CT in patients with end-stage renal disease?
Atsushi Tani, Yoriko Kajiya, Masanori Nakajo and Masayuki Nakajo

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1913;
You have access
Functional imaging in paragangliomas with 68Ga-DOTA-TOC PET/CT and 123I-MIBG SPECT/CT imaging
Alexander Kroiss, Daniel Putzer, Andreas Frech, Clemens Decristoforo, Christian Uprimny, Rudolf Gasser, Gustav Fraedrich, Barry Shulkin, Christoph Url and Irene Virgolini

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1930;
You have access
The diagnostic value of dual-phase 99mTc-MIBI scintigraphy combined with SPECT/CT for primary hyperparathyroidism
Peng-yue Wu and Hongcheng Shi

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1883;
You have access
Hypothyreosis induced myopathia in patients with DTC undergoing radioiodine treatment
Torjan Haslerud, Alexander Schreiber, Amir Sabet, Hojjat Ahmadzadehfar, Marianne Muckle, Francisco Huertos-Lopez and Samer Ezziddin

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1899;
You have access
68Ga-DOTATATE uptake of ileal neuroendocrine tumors: Correlation with time to progression under treatment with sandostatin LAR 30
Julia Geisler, Christoph Auernhammer, Harun Ilhan, Peter Bartenstein, Marcus Hacker and Alexander Haug

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1876;
You have access
Preablation serum thyroglobulin is the most predictive factor for successful I-131 therapy in differentiated thyroid cancer
Hee Jeong Park, Sang-Geon Cho, Sae-Ryung Kang, Jahae Kim, Su Woong Yoo, Ari Chong, Seong Young Kwon, Jung Joon Min, Ho-Chun Song and Hee-Seung Bom

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1861;
You have access
Comparison of preablative thyroglobulin level with the other risk factors in determining papillary thyroid cancer prognosis
Elgin Ozkan, Yasemin Genc, Mine Araz, Cigdem Soydal, Gulseren Aras and Kemal Kir

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1869;
You have access
Clinical standardized quantitative comparison of [⁶⁸Ga]Ga-DOTA-TOC and [⁶⁸Ga]Ga-DOTA-TATE
Jens Sörensen, Irina Velikyan, Anders Sundin, Mark Lubberink, Mattias Sandstrom, Ulrike Garske-Román, Hans Lundqvist, Dan Granberg and Barbro Eriksson

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1863;
You have access
Comparison of molecular and morphological response criteria for assessment of response to peptide receptor radionuclide therapy
Harshad Kulkarni and Richard Baum

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1862;
You have access
Radiation doses during sleep with the patients undergoing radioiodine therapy after discharge: Too stringent to follow some protocols of the radiation safety guidelines
Jung Mi Park, Eun-ha Moon, Sang Woo Kim and Hong Jun Choi

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1865;

Main menu

User menu

Search

More articles from MTA II: Endocrine/Neuroendocrine Posters

Pages